Abstract：
\"Partnership Care Model (PCM)\", which is the first partnership conceptual framework founded on the Iranian culture to control chronic diseases, has been recently used in different fields of nursing research with no levels of valid evidence to support its application. Therefore, this systematic review and meta-analysis sought to clarify the impacts of interventions developed based on PCM on quality of life (QoL), sleep quality, anxiety, and depression among adults and children with chronic diseases.
International data sources (e.g., PubMed, Web of Science, Scopus) and national databases (e.g., SID, MagIran, IranDoc, IRCT) were searched from 2001 to September 23, 2023, to find Randomized Controlled Trials (RCTs) on PCM-driven interventions for the experimental groups versus no intervention or standard care groups. The studies\' methodological quality and evidence quality were rated utilizing the Cochrane risk of bias instruction and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Data were pooled by a random-effects approach employing STATA (vers. 11.2).
Eighteen RCTs, reported in 22 publications, were qualified. The PCM compared to the standard care significantly improved the QoL among both adults (10 effect sizes [ESs], mean difference [MD]: 3.17, P < 0.001) and children (4 ESs, MD: 4.45, P < 0.001). Likewise, the intervention enhanced adults\' sleep quality (3 ESs, MD: 7.15, P < 0.001). The anxiety of adults and children was also significantly lower in the PCM group (4 ESs, MD: -4.52, P = 0.001; 2 ESs, MD: -4.04, P < 0.001, respectively). However, regarding depression, a significant effect of PCM was found only among children (3 ESs, MD: -7.99, P = 0.011). The methodological quality of the studies and the evidence quality were undesirable.
The PCM had a promising influence on the caring of adults and children suffering from chronic diseases. However, additional high-quality RCTs are needed to generate a higher quality of evidence concerning the clinical benefits of the PCM.
CRD42021253790.
International data sources (e.g., PubMed, Web of Science, Scopus) and national databases (e.g., SID, MagIran, IranDoc, IRCT) were searched from 2001 to September 23, 2023, to find Randomized Controlled Trials (RCTs) on PCM-driven interventions for the experimental groups versus no intervention or standard care groups. The studies\' methodological quality and evidence quality were rated utilizing the Cochrane risk of bias instruction and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Data were pooled by a random-effects approach employing STATA (vers. 11.2).
Eighteen RCTs, reported in 22 publications, were qualified. The PCM compared to the standard care significantly improved the QoL among both adults (10 effect sizes [ESs], mean difference [MD]: 3.17, P < 0.001) and children (4 ESs, MD: 4.45, P < 0.001). Likewise, the intervention enhanced adults\' sleep quality (3 ESs, MD: 7.15, P < 0.001). The anxiety of adults and children was also significantly lower in the PCM group (4 ESs, MD: -4.52, P = 0.001; 2 ESs, MD: -4.04, P < 0.001, respectively). However, regarding depression, a significant effect of PCM was found only among children (3 ESs, MD: -7.99, P = 0.011). The methodological quality of the studies and the evidence quality were undesirable.
The PCM had a promising influence on the caring of adults and children suffering from chronic diseases. However, additional high-quality RCTs are needed to generate a higher quality of evidence concerning the clinical benefits of the PCM.
CRD42021253790.
摘要：
背景：\“伙伴关系护理模式（PCM）\”，这是第一个建立在伊朗文化基础上的控制慢性病的伙伴关系概念框架，最近已用于护理研究的不同领域，没有有效的证据来支持其应用。因此,本系统综述和荟萃分析旨在阐明基于PCM开发的干预措施对生活质量(QoL)的影响，睡眠质量,焦虑,患有慢性疾病的成人和儿童的抑郁症。
方法：国际数据源(例如，PubMed,WebofScience,Scopus)和国家数据库(例如，SID,MagIran,伊朗医生，从2001年至2023年9月23日对IRCT）进行了搜索，以找到实验组与无干预或标准护理组相比，PCM驱动的干预措施的随机对照试验（RCT）。使用Cochrane偏倚指导风险和建议评估等级对研究的方法学质量和证据质量进行评级，发展,和评估（等级）。数据通过使用STATA(vers。11.2).
结果：18项RCT，在22种出版物中报道，是合格的。与标准护理相比，PCM显著提高了两名成年人的QoL(10种效应大小[ES]，平均差[MD]：3.17，P<0.001）和儿童（4个ESs，MD:4.45,P<0.001)。同样，干预提高了成年人的睡眠质量(3个ESs，MD：7.15，P<0.001）。PCM组成人和儿童的焦虑也显著降低(4个ESs，MD：-4.52，P=0.001；2ESs，MD：分别为-4.04，P<0.001）。然而,关于抑郁症，仅在儿童中发现PCM的显着影响(3个ESs，MD:-7.99,P=0.011)。研究的方法学质量和证据质量均不理想。
结论：PCM对患有慢性疾病的成人和儿童的护理具有积极的影响。然而,需要额外的高质量随机对照试验,以产生更高质量的关于PCM临床益处的证据.
■CRD42021253790。
方法：国际数据源(例如，PubMed,WebofScience,Scopus)和国家数据库(例如，SID,MagIran,伊朗医生，从2001年至2023年9月23日对IRCT）进行了搜索，以找到实验组与无干预或标准护理组相比，PCM驱动的干预措施的随机对照试验（RCT）。使用Cochrane偏倚指导风险和建议评估等级对研究的方法学质量和证据质量进行评级，发展,和评估（等级）。数据通过使用STATA(vers。11.2).
结果：18项RCT，在22种出版物中报道，是合格的。与标准护理相比，PCM显著提高了两名成年人的QoL(10种效应大小[ES]，平均差[MD]：3.17，P<0.001）和儿童（4个ESs，MD:4.45,P<0.001)。同样，干预提高了成年人的睡眠质量(3个ESs，MD：7.15，P<0.001）。PCM组成人和儿童的焦虑也显著降低(4个ESs，MD：-4.52，P=0.001；2ESs，MD：分别为-4.04，P<0.001）。然而,关于抑郁症，仅在儿童中发现PCM的显着影响(3个ESs，MD:-7.99,P=0.011)。研究的方法学质量和证据质量均不理想。
结论：PCM对患有慢性疾病的成人和儿童的护理具有积极的影响。然而,需要额外的高质量随机对照试验,以产生更高质量的关于PCM临床益处的证据.
■CRD42021253790。
